Racial and Ethnic Disparities in Research and Clinical Trials.
Clinical trials
Dermatology
Diversity
Ethnic skin
Health disparities
Health equity
Research
Skin of color
Journal
Dermatologic clinics
ISSN: 1558-0520
Titre abrégé: Dermatol Clin
Pays: United States
ID NLM: 8300886
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
entrez:
18
3
2023
pubmed:
19
3
2023
medline:
22
3
2023
Statut:
ppublish
Résumé
Clinical trials are an essential component of research for determining the safety and efficacy of treatments for medical diseases. In order for the results of clinical trials to be generalizable to diverse populations, they must include participants at ratios that are reflective of national and global populations. A significant number of dermatology studies not only lack racial/ethnic diversity but also fail to report data on minority recruitment and enrollment. Reasons for this are multifold and are discussed in this review. Although steps have been implemented to improve this issue, greater efforts are needed for sustained and meaningful change.
Identifiants
pubmed: 36933925
pii: S0733-8635(22)00100-0
doi: 10.1016/j.det.2022.10.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
351-358Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest Dr N. Elbuluk is the director of the USC Dermatology Diversity and Inclusion Program as well as the Director of the Skin of Color and Pigmentary Disorders Program at the USC Department of Dermatology, Keck School of Medicine.